Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 65

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Cardiac RKIP induces a beneficial β-adrenoceptor–dependent positive inotropy

Schmid, Evelyn, Neef, Stefan, Berlin, Christopher, Tomasovic, Angela, Kahlert, Katrin, Nordbeck, Peter, Deiss, Katharina, Denzinger, Sabrina, Herrmann, Sebastian, Wettwer, Erich, Weidendorfer, Markus, Becker, Daniel, Schäfer, Florian, Wagner, Nicole, Ergün, Süleyman, Schmitt, Joachim P, Katus, Hugo A, Weidemann, Frank, Ravens, Ursula, Maack, Christoph, Hein, Lutz, Ertl, Georg, Müller, Oliver J, Maier, Lars S, Lohse, Martin J, Lorenz, Kristina · 2015 · Nature Medicine

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nm.3972

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 66

  1. McMurray, J.J.V. et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 33, 1787–1847 (2012). · DOI · Paper page
  2. Tacon, C.L., McCaffrey, J. & Delaney, A. Dobutamine for patients with severe heart failure: a systematic review and meta-analysis of randomised controlled trials. Intensive Care Med. 38, 359–367 (2012). · DOI · Paper page
  3. Engelhardt, S., Hein, L., Wiesmann, F. & Lohse, M.J. Progressive hypertrophy and heart failure in β1-adrenergic receptor transgenic mice. Proc. Natl. Acad. Sci. USA 96, 7059–7064 (1999). · DOI · Paper page
  4. Communal, C., Singh, K., Sawyer, D.B. & Colucci, W.S. Opposing effects of β1- and β2-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin–sensitive G protein. Circulation 100, 2210–2212 (1999). · DOI · Paper page
  5. Liggett, S.B. et al. Early and delayed consequences of β2-adrenergic receptor overexpression in mouse hearts: critical role for expression level. Circulation 101, 1707–1714 (2000). · DOI · Paper page
  6. Rockman, H.A., Koch, W.J. & Lefkowitz, R.J. Seven-transmembrane-spanning receptors and heart function. Nature 415, 206–212 (2002). · DOI · Paper page
  7. Xiao, R.-P. β-adrenergic signaling in the heart: dual coupling of the β2-adrenergic receptor to Gs and Gi proteins. Sci. STKE 2001, re15 (2001).
  8. Ahmet, I. et al. Cardioprotective and survival benefits of long-term combined therapy with β2-adrenoreceptor (AR) agonist and β1-AR blocker in dilated cardiomyopathy postmyocardial infarction. J. Pharmacol. Exp. Ther. 325, 491–499 (2008). · DOI
  9. Raake, P.W. et al. G protein–coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure. Circ. Res. 103, 413–422 (2008). · DOI
  10. Raake, P.W. et al. Cardiac G protein–coupled receptor kinase 2 ablation induces a novel Ca2+-handling phenotype resistant to adverse alterations and remodeling after myocardial infarction. Circulation 125, 2108–2118 (2012). · DOI
  11. Völkers, M. et al. The inotropic peptide β−ARKct improves AR responsiveness in normal and failing cardiomyocytes through Gβγ-mediated L-type calcium current disinhibition. Circ. Res. 108, 27–39 (2011). · doi:10.1161/circresaha.110.225201
  12. Fu, X., Koller, S., Abd Alla, J. & Quitterer, U. Inhibition of G protein–coupled receptor kinase 2 (GRK2) triggers the growth-promoting mitogen-activated protein kinase (MAPK) pathway. J. Biol. Chem. 288, 7738–7755 (2013). · DOI
  13. Kairouz, V., Lipskaia, L., Hajjar, R.J. & Chemaly, E.R. Molecular targets in heart failure gene therapy: current controversies and translational perspectives. Ann. NY Acad. Sci. 1254, 42–50 (2012). · DOI · Paper page
  14. Matkovich, S.J. et al. Cardiac-specific ablation of G protein receptor kinase 2 redefines its roles in heart development and β-adrenergic signaling. Circ. Res. 99, 996–1003 (2006). · DOI · Paper page
  15. Lorenz, K., Lohse, M.J. & Quitterer, U. Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature 426, 574–579 (2003). · DOI · Paper page
  16. Yeung, K. et al. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 401, 173–177 (1999). · DOI · Paper page
  17. Deiss, K., Kisker, C., Lohse, M.J. & Lorenz, K. Raf kinase inhibitor protein (RKIP) dimer formation controls its target switch from Raf1 to G protein–coupled receptor kinase (GRK) 2. J. Biol. Chem. 287, 23407–23417 (2012). · DOI
  18. Corbit, K.C. et al. Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein. J. Biol. Chem. 278, 13061–13068 (2003). · DOI · Paper page
  19. Palczewski, K., Buczyłko, J., Lebioda, L., Crabb, J.W. & Polans, A.S. Identification of the N-terminal region in rhodopsin kinase involved in its interaction with rhodopsin. J. Biol. Chem. 268, 6004–6013 (1993). · DOI
  20. Lorenz, K., Schmitt, J.P., Schmitteckert, E.M. & Lohse, M.J. A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy. Nat. Med. 15, 75–83 (2009). · DOI · Paper page
  21. Ruppert, C. et al. Interference with ERKThr188 phosphorylation impairs pathological but not physiological cardiac hypertrophy. Proc. Natl. Acad. Sci. USA 110, 7440–7445 (2013). · DOI
  22. Braz, J.C. et al. PKC-α regulates cardiac contractility and propensity toward heart failure. Nat. Med. 10, 248–254 (2004). · DOI · Paper page
  23. Hambleton, M. et al. Pharmacological- and gene therapy–based inhibition of protein kinase Cα/β enhances cardiac contractility and attenuates heart failure. Circulation 114, 574–582 (2006). · DOI
  24. Dorn, G.W. et al. Sustained in vivo cardiac protection by a rationally designed peptide that causes ɛ protein kinase C translocation. Proc. Natl. Acad. Sci. USA 96, 12798–12803 (1999). · DOI · Paper page
  25. Lehnart, S.E., Maier, L.S. & Hasenfuss, G. Abnormalities of calcium metabolism and myocardial contractility depression in the failing heart. Heart Fail. Rev. 14, 213–224 (2009). · DOI
  26. Rohrer, D.K., Schauble, E.H., Desai, K.H., Kobilka, B.K. & Bernstein, D. Alterations in dynamic heart rate control in the β1-adrenergic receptor knockout mouse. Am. J. Physiol. 274, H1184–H1193 (1998).
  27. Chruscinski, A.J. et al. Targeted disruption of the β2-adrenergic receptor gene. J. Biol. Chem. 274, 16694–16700 (1999). · DOI · Paper page
  28. Ling, H. et al. Requirement for Ca2+/calmodulin–dependent kinase II in the transition from pressure overload–induced cardiac hypertrophy to heart failure in mice. J. Clin. Invest. 119, 1230–1240 (2009). · DOI · Paper page
  29. Shiferaw, Y., Aistrup, G.L. & Wasserstrom, J.A. Intracellular Ca2+ waves, afterdepolarizations and triggered arrhythmias. Cardiovasc. Res. 95, 265–268 (2012). · DOI
  30. Guo, T., Zhang, T., Mestril, R. & Bers, D.M. Ca2+/calmodulin-dependent protein kinase II phosphorylation of ryanodine receptor does affect calcium sparks in mouse ventricular myocytes. Circ. Res. 99, 398–406 (2006). · DOI · Paper page
  31. Bers, D.M. Ryanodine receptor S2808 phosphorylation in heart failure: smoking gun or red herring. Circ. Res. 110, 796–799 (2012). · doi:10.1161/circresaha.112.265579
  32. Eschenhagen, T. Is ryanodine receptor phosphorylation key to the fight or flight response and heart failure? J. Clin. Invest. 120, 4197–4203 (2010). · doi:10.1172/jci45251
  33. Respress, J.L. et al. Role of RyR2 phosphorylation at S2814 during heart failure progression. Circ. Res. 110, 1474–1483 (2012). · DOI · Paper page
  34. Dobrev, D. & Wehrens, X.H.T. Role of RyR2 phosphorylation in heart failure and arrhythmias: controversies around ryanodine receptor phosphorylation in cardiac disease. Circ. Res. 114, 1311–1319 (2014). · DOI · Paper page
  35. Shan, J. et al. Phosphorylation of the ryanodine receptor mediates the cardiac fight or flight response in mice. J. Clin. Invest. 120, 4388–4398 (2010). · DOI · Paper page
  36. Anderson, M.E., Brown, J.H. & Bers, D.M. CaMKII in myocardial hypertrophy and heart failure. J. Mol. Cell. Cardiol. 51, 468–473 (2011). · DOI · Paper page
  37. Huke, S. & Bers, D.M. Ryanodine receptor phosphorylation at serine 2030, 2808 and 2814 in rat cardiomyocytes. Biochem. Biophys. Res. Commun. 376, 80–85 (2008). · DOI
  38. Orchard, C. & Brette, F. T-tubules and sarcoplasmic reticulum function in cardiac ventricular myocytes. Cardiovasc. Res. 77, 237–244 (2008). · DOI
  39. Nikolaev, V.O. et al. β2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation. Science 327, 1653–1657 (2010). · DOI · Paper page
  40. Kuschel, M. et al. Gi protein–mediated functional compartmentalization of cardiac β2-adrenergic signaling. J. Biol. Chem. 274, 22048–22052 (1999). · DOI · Paper page
  41. Xiao, R.P. et al. Coupling of β2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes. Circ. Res. 84, 43–52 (1999). · DOI · Paper page
  42. Daaka, Y., Luttrell, L.M. & Lefkowitz, R.J. Switching of the coupling of the β2-adrenergic receptor to different G proteins by protein kinase A. Nature 390, 88–91 (1997). · DOI · Paper page
  43. Talan, M.I., Ahmet, I., Xiao, R.-P. & Lakatta, E.G. β2-AR agonists in treatment of chronic heart failure: long path to translation. J. Mol. Cell. Cardiol. 51, 529–533 (2011). · DOI
  44. Chesley, A. et al. The β2-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through Gi-dependent coupling to phosphatidylinositol 3′ kinase. Circ. Res. 87, 1172–1179 (2000). · DOI · Paper page
  45. Kranias, E.G. & Hajjar, R.J. Modulation of Cardiac Contractility by the Phopholamban/SERCA2a Regulatome. Circ. Res. 110, 1646–1660 (2012). · DOI · Paper page
  46. Greenberg, B. et al. Design of a phase 2b trial of intracoronary administration of AAV1/SERCA2a in patients with advanced heart failure. JACC: Heart Failure 2, 84–92 (2014).
  47. Antos, C.L. et al. Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase A. Circ. Res. 89, 997–1004 (2001). · DOI · Paper page
  48. El-Armouche, A. et al. Phosphatase inhibitor-1–deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy. Cardiovasc. Res. 80, 396–406 (2008). · DOI
  49. Koval, O.M. et al. CaV1.2 β-subunit coordinates CaMKII-triggered cardiomyocyte death and afterdepolarizations. Proc. Natl. Acad. Sci. USA 107, 4996–5000 (2010). · DOI
  50. Rohrer, D.K. et al. Targeted disruption of the mouse β1-adrenergic receptor gene: developmental and cardiovascular effects. Proc. Natl. Acad. Sci. USA 93, 7375–7380 (1996). · DOI · Paper page
  51. Rohrer, D.K., Chruscinski, A., Schauble, E.H., Bernstein, D. & Kobilka, B.K. Cardiovascular and metabolic alterations in mice lacking both β1- and β2-adrenergic receptors. J. Biol. Chem. 274, 16701–16708 (1999). · DOI · Paper page
  52. Vidal, M., Wieland, T., Lohse, M.J. & Lorenz, K. β-adrenergic receptor stimulation causes cardiac hypertrophy via a Gβγ/Erk-dependent pathway. Cardiovasc. Res. 96, 255–264 (2012). · DOI
  53. Lorenz, K., Stathopoulou, K., Schmid, E., Eder, P. & Cuello, F. Heart failure–specific changes in protein kinase signalling. Pflugers Arch. 466, 1151–1162 (2014). · DOI
  54. Liggett, S.B. et al. The Ile164 β2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure. J. Clin. Invest. 102, 1534–1539 (1998). · DOI · Paper page
  55. Siedlecka, U. et al. Effects of clenbuterol on contractility and Ca2+ homeostasis of isolated rat ventricular myocytes. Am. J. Physiol. Heart Circ. Physiol. 295, H1917–H1926 (2008). · DOI
  56. Paur, H. et al. High levels of circulating epinephrine trigger apical cardiodepression in a β2-adrenergic receptor/Gi-dependent manner: a new model of Takotsubo cardiomyopathy. Circulation 126, 697–706 (2012). · DOI · Paper page
  57. Shao, Y. et al. Novel rat model reveals important roles of β-adrenoreceptors in stress-induced cardiomyopathy. Int. J. Cardiol. 168, 1943–1950 (2013). · doi:10.1016/j.ijcard.2012.12.092
  58. Grueter, C.E., Abiria, S.A., Wu, Y., Anderson, M.E. & Colbran, R.J. Differential regulated interactions of calcium/calmodulin-dependent protein kinase ii with isoforms of voltage-gated calcium channel β subunits. Biochemistry 47, 1760–1767 (2008). · DOI
  59. El-Armouche, A., Pamminger, T., Ditz, D., Zolk, O. & Eschenhagen, T. Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts. Cardiovasc. Res. 61, 87–93 (2004). · DOI
  60. Ruiz-Gómez, A. et al. Phosphorylation of phosducin and phosducin-like protein by G protein–coupled receptor kinase 2. J. Biol. Chem. 275, 29724–29730 (2000). · doi:10.1074/jbc.m001864200
  61. Nakayama, H. et al. Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. J. Clin. Invest. 117, 2431–2444 (2007). · DOI · Paper page
  62. Schultz, J.E., Hsu, A.K., Barbieri, J.T., Li, P.L. & Gross, G.J. Pertussis toxin abolishes the cardioprotective effect of ischemic preconditioning in intact rat heart. Am. J. Physiol. 275, H495–H500 (1998).
  63. Oostendorp, J. & Kaumann, A.J. Pertussis toxin suppresses carbachol-evoked cardiodepression but does not modify cardiostimulation mediated through β1- and putative β4-adrenoceptors in mouse left atria: no evidence for β2- and β3-adrenoceptor function. Naunyn Schmiedebergs Arch. Pharmacol. 361, 134–145 (2000). · DOI
  64. Braz, J.C., Bueno, O.E., De Windt, L.J. & Molkentin, J.D. PKCα regulates the hypertrophic growth of cardiomyocytes through extracellular signal–regulated kinase 1/2 (ERK1/2). J. Cell Biol. 156, 905–919 (2002). · DOI · Paper page
  65. Picht, E., Zima, A.V., Blatter, L.A. & Bers, D.M. SparkMaster: automated calcium spark analysis with ImageJ. Am. J. Physiol. Cell Physiol. 293, C1073–C1081 (2007). · DOI · Paper page
  66. Barry, P.H. JPCalc, a software package for calculating liquid junction potential corrections in patch-clamp, intracellular, epithelial and bilayer measurements and for correcting junction potential measurements. J. Neurosci. Methods 51, 107–116 (1994). · DOI · Paper page

Cited by

See all 65

Metadata

Authors
Schmid, E., Neef, S., Berlin, C., Tomasovic, A., Kahlert, K., Nordbeck, P., Deiss, K., Denzinger, S., Herrmann, S., Wettwer, E., Weidendorfer, M., Becker, D., Schäfer, F., Wagner, N., Ergün, S., Schmitt, J. P., Katus, H. A., Weidemann, F., Ravens, U., Maack, C., Hein, L., Ertl, G., Müller, O. J., Maier, L. S., Lohse, M. J., & Lorenz, K.
Venue
Nature Medicine
Published
2015-10-19
Volume
21
Issue
11
Pages
1298-1306
ISSN
  • 1078-8956
  • 1546-170X
Cited by
65
References
4
Language
en
Update notices
erratum (2016-02-04)
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cardiac RKIP induces a beneficial β-adrenoceptor–dependent positive inotropy. https://app.cochat.ai/papers/10.1038/nm.3972
The paper
Schmid, E., Neef, S., Berlin, C., Tomasovic, A., Kahlert, K., Nordbeck, P., Deiss, K., Denzinger, S., Herrmann, S., Wettwer, E., Weidendorfer, M., Becker, D., Schäfer, F., Wagner, N., Ergün, S., Schmitt, J. P., Katus, H. A., Weidemann, F., Ravens, U., . . . Lorenz, K. (2015). Cardiac RKIP induces a beneficial β-adrenoceptor–dependent positive inotropy. Nature Medicine. https://doi.org/10.1038/nm.3972

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.